Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assurant (AIZ) Cash & Equivalents (2016 - 2025)

Assurant (AIZ) has 17 years of Cash & Equivalents data on record, last reported at $1.8 billion in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 1.46% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 1.46%, while the annual FY2025 figure was $1.8 billion, 1.46% up from the prior year.
  • Cash & Equivalents reached $1.8 billion in Q4 2025 per AIZ's latest filing, up from $1.7 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.0 billion in Q4 2021 and bottomed at $1.2 billion in Q2 2022.
  • Average Cash & Equivalents over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: dropped 29.49% in 2022, then surged 30.24% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $2.0 billion in 2021, then fell by 24.7% to $1.5 billion in 2022, then increased by 5.9% to $1.6 billion in 2023, then rose by 11.08% to $1.8 billion in 2024, then grew by 1.46% to $1.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $1.8 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.5 billion in Q2 2025.